Eureka Therapeutics, Inc
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
2
Funding Rounds
$105.0m
Money raised
Funding series
Funding Series Analysis
The company Eureka Therapeutics, Inc has raised a total of $45m in funding over 2 rounds.
Key Insights:
- Eureka Therapeutics Series E round, March 2020: $45m
- Eureka Therapeutics Inc funding round, January 2018: $60m
Eureka Therapeutics Series E round, March 2020
$45m
Eureka Therapeutics Inc funding round, January 2018
$60m
Industries
Eureka Therapeutics, Inc is active in the following industries: